Low acceptance of treatment in the elderly for the secondary prevention of osteoporotic fracture in the acute rehabilitation setting

Aging Clinical and Experimental Research

Volumn 22, Issue 3, 2010, Pages 231-237

  Berry, Sarah D ^a,b   Misra, Devyani ^a,b   Hannan, Marian T ^a,b   Kiel, Douglas P ^a,b  

^a Hebrew Senior Life   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Fracture; Osteoporosis; Rehabilitation; Secondary prevention

Indexed keywords

ALENDRONIC ACID; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; VITAMIN D;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITION; DIET SUPPLEMENTATION; ELDERLY CARE; EVIDENCE BASED PRACTICE; FALLING; FEMALE; FRAGILITY FRACTURE; FUNCTIONAL STATUS; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; HUMERUS FRACTURE; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PROFESSIONAL PRACTICE; REHABILITATION CARE; REHABILITATION CENTER; SCREENING; SECONDARY PREVENTION; TREATMENT DURATION; UNITED STATES; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

EID: 77955385344     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/BF03324801     Document Type: Article

References (23)

1. McKinley ED, Thompson JW, Briefer-French J, Wilcox LS, Weisman CS, Andrews WC. Performance indicators in women's health: incorporating women's health in the health plan employer data and information set (HEDIS). Womens Health Issues 2002; 12: 46-58. (Pubitemid 34084785)
2. Physician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington D.C., 2008.
3. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003; 163: 2165-72. (Pubitemid 37248781)
4. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-39. (Pubitemid 30174026)
5. Berry SD, Samelson EJ, Hannan MT et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med 2007; 167: 1971-6.
6. Nguyen-Oghalai TU, Kuo YF, Zhang DD, Graham JE, Goodwin JS, Ottenbacher KJ. Discharge setting for patients with hip fracture: trends from 2001 to 2005. J Am Geriatr Soc 2008; 56: 1063-8.
7. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003; (4): CD000340.
8. Ottenbacher KJ, Hsu Y, Granger CV, Fiedler RC. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil 1996; 77: 1226-32. (Pubitemid 26424833)
9. Nymark T, Lauritsen JM, Ovesen O, Rock ND, Jeune B. Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study. Osteoporos Int 2006; 17: 1353-7. (Pubitemid 44127322)
10. Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis Rheum 2006; 55: 729-35. (Pubitemid 44619186)
11. Hadji P, Minne H, Pfeifer M et al. Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II). Joint Bone Spine 2008; 75: 303-10.
12. Lyles KW, Colon-Emeric CS, Magaziner JS et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007; 357: nihpa40967.
13. Wells G, Cranney A, Peterson J et al. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008: CD004523. (Pubitemid 351824594)
14. Wells GA, Cranney A, Peterson J et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008: CD001155. (Pubitemid 351807494)
15. Giangregorio L, Papaioannou A, Thabane L et al. Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord 2008; 9: 38.
16. Mauck KF, Cuddihy MT, Trousdale RT, Pond GR, Pankratz VS, Melton LJ 3rd. The decision to accept treatment for osteoporosis following hip fracture: exploring the woman's perspective using a stage-of-change model. Osteoporos Int 2002; 13: 560-4.
17. Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH. Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med 2008; 23: 1815-21.
18. Forkan R, Pumper B, Smyth N, Wirkkala H, Ciol MA, Shumway-Cook A. Exercise adherence following physical therapy intervention in older adults with impaired balance. Phys Ther 2006; 86: 401-10.
19. Gardner MJ, Brophy RH, Demetrakopoulos D et al. Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am 2005; 87: 3-7. (Pubitemid 40094132)
20. Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 2007; 297: 387-94. (Pubitemid 46155800)
21. Feldstein AC, Schneider J, Smith DH et al. Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture. Osteoporos Int 2008; 19: 1527-40.
22. Perreault S, Dragomir A, Desgagne A et al. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 2005; 14: 685-95. (Pubitemid 41489448)
23. Curtis JR, Xi J, Westfall AO et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care 2009; 47: 334-41.